The Invention Return on NIH Investments

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NATIONAL EYE INSTITUTEFrom 1980 to 2007, a little more than 8 percent of the grants given out by the National Institutes of Health (NIH) led to patents, according to an analysis published in Science Thursday (March 30). Roughly 30 percent of grants over that time period were cited by patents, indicating indirect contributions to inventions as well.

“Their findings here demonstrate that there is commercial value to funding basic science,” Ross DeVol, chief research officer at the Milken Institute, told Nature News. “That may be the most important piece of this, to be quite frank.”

The authors of the study looked at more than 365,000 grants awarded during the time period, of which nearly 31,000 were directly linked to patented inventions.

They also found that basic research was nearly as likely to contribute to a patent as applied projects. The authors separated grants awarded through a request for applications (RFA)—indicating a focus on addressing a particular disease—from those that were unsolicited—likely representing more basic science—and discovered a similar citation rate in associated patents.

“One interpretation of this is that ‘basic’ research is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours